Country - Australia
Summary - Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne
Deadline - Jun 30, 2026
MT reference number - 10264216
Product classification -
Address - Australia
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 10264216
Document Type - Tender Notices
Description - Location : Melbourne, Victoria, AustraliaSeqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in Melbourne, Australia.The facility will be a significant addition to the company’s global manufact uring and supply chain for the influenza vaccine, including the facilities in Holly Springs, North Carolina, US, Liverpool, UK, and Parkville, Australia.The new plant will be utilised to manufacture influenza vaccines for both pandemics and seasonal vaccination programmes, using advanced cell-based technology. It will produce products for the domestic market and export, help Victoria’s 1,000+ STEM workers, and have an estimated supply chain of
Mt Ref Id - 10264216
Deadline - Jun 30, 2026
View more tenders for
Australia Tenders